Clinical trial
"Longitudinal Analysis of Amylin Levels in Migraine Patients Undergoing an Anti- CGRP/CGRPr Treatment"
NCT06692088 is registered in ClinicalTrials.gov with Fundación Marques de Valdecilla as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- "Longitudinal Analysis of Amylin Levels in Migraine Patients Undergoing an Anti- CGRP/CGRPr Treatment"
- Lead sponsor
- Fundación Marques de Valdecilla
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- March 1, 2025
- Completion date
- December 31, 2026
- Enrollment
- 216 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
high frequency episodic migraine and chronic migraine